Bluebirdbio
2 known investors
Genetix Biotherapeutics (formerly bluebird bio) develops gene therapies for patients with rare genetic diseases including sickle cell disease, beta-thalassemia, and cerebral adrenoleukodystrophy. The therapies use modified blood stem cells to restore function of affected genes and offer potential cures rather than symptom management.
BiotechLongevityMedical Devices
Founders & leadership
DM
David MeekChief Executive Officer
BR
Brian RileyPresident & Chief Technical Officer
JL
Joanne LagerChief Medical Officer
WD
Wendy DiCiccoChief Financial Officer
AC
Adrian ChaissonChief of Staff